Skip Nav Destination
Issues
June 2017
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2017, Vol. 40, No. 6
Beilage
ONKOIMMUN 2/17
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): I–VIII.
https://doi.org/10.1159/000478252
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 313–316.
https://doi.org/10.1159/000477476
Editorial
Head and Neck Cancer - New Insights into a Heterogeneous Disease
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 318–319.
https://doi.org/10.1159/000477255
Original Article
Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Nora Wuerdemann; Claus Wittekindt; Shachi Jenny Sharma; Elena-Sophie Prigge; Miriam Reuschenbach; Stefan Gattenlöhner; Jens Peter Klussmann; Steffen Wagner
Oncol Res Treat (2017) 40 (6): 320–327.
https://doi.org/10.1159/000477097
Review Article
Epidemiology and Molecular Biology of Head and Neck Cancer
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 328–332.
https://doi.org/10.1159/000477127
Human Papillomavirus-Related Head and Neck Cancer
Topic Article Package:
Topic Article Package: Cytology
Special Collection:
Focus Article
Subject Area:
Oncology
Steffen Wagner; Shachi Jenny Sharma; Nora Wuerdemann; Jennifer Knuth; Henrike Reder; Claus Wittekindt; Jens Peter Klussmann
Oncol Res Treat (2017) 40 (6): 334–340.
https://doi.org/10.1159/000477252
Novel Treatment Options in Head and Neck Cancer
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 342–346.
https://doi.org/10.1159/000477254
The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 347–352.
https://doi.org/10.1159/000477128
Original Article
Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy
Subject Area:
Oncology
Julie Van Dievel; Raf Sciot; Marion Delcroix; Raf O. Vandeweyer; Maria Debiec-Rychter; Barbara Dewaele; Jasmien Cornillie; Thomas Van Cann; Bart Meyns; Patrick Schöffski
Oncol Res Treat (2017) 40 (6): 353–359.
https://doi.org/10.1159/000476036
Malignancy in Solitary Thyroid Nodules: Evaluation of Risk Factors
Subject Area:
Oncology
Osman Uyar; Bahadır Cetin; Bulent Aksel; Lutfi Dogan; Kemal Beksac; Gokhan G. Akgul; Ugur Berberoglu; Mehmet A. Gulcelik
Oncol Res Treat (2017) 40 (6): 360–363.
https://doi.org/10.1159/000464409
Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma
Subject Area:
Oncology
Manlio Mencoboni; Rosa A. Filiberti; Paola Taveggia; Federica Grosso; Giulia Pasello; Lisette Del Corso; Alberto Muzio; Valentina Polo; Paolo Zucali; Giovanni L. Ceresoli; Hector J. Soto Parra; Laura Auriati; Claudio Simonassi
Oncol Res Treat (2017) 40 (6): 364–369.
https://doi.org/10.1159/000464410
NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma
Subject Area:
Oncology
Xiaoliang Wu; Zuan-Fu Lim; Zhongwen Li; Ling Gu; Wenjuan Ma; Qianghua Zhou; Huifang Su; Xing Wang; Xianzi Yang; Zhenfeng Zhang
Oncol Res Treat (2017) 40 (6): 370–374.
https://doi.org/10.1159/000464465
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 376–379.
https://doi.org/10.1159/000477111
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 380–381.
https://doi.org/10.1159/000477502
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 382–383.
https://doi.org/10.1159/000477503
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 384–385.
https://doi.org/10.1159/000477504
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 386–387.
https://doi.org/10.1159/000477505
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 389.
https://doi.org/10.1159/000475788
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 390–392.
https://doi.org/10.1159/000477506
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (6): 394–396.
https://doi.org/10.1159/000477110
